Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »Researchers in British Columbia, Canada, conducted a retrospective cohort study with 1,105 adult patients to determine the risk of glomerular disease relapse following COVID-19 vaccination.
Read More »A recent study investigated COVID-19 outcomes in patients with primary and secondary immunodeficiency, comparing hospitalization rates and mortality between both vaccinated and unvaccinated patients.
Read More »A study published in the Journal of Autoimmunity evaluated the immune response of Pfizer and Moderna’s mRNA COVID-19 vaccines in participants with autoimmune systemic diseases. In total, serum samples from 244 AD patients were collected 2-4 weeks and six months after their first vaccine cycle, and 2-4 weeks following their booster dose; 502 people from the general population were used as a control group.
Read More »